Quince Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Quince Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2019 to Q2 2024.
  • Quince Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 927 %, a 67.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 927 -1.92K -67.5% Jun 30, 2024
Q1 2024 1.36K -886 -39.4% Mar 31, 2024
Q4 2023 2.03K +397 +24.2% Dec 31, 2023
Q3 2023 3.46K +2.3K +197% Sep 30, 2023
Q2 2023 2.85K +1.88K +194% Jun 30, 2023
Q1 2023 2.25K +1.43K +175% Mar 31, 2023
Q4 2022 1.64K +840 +105% Dec 31, 2022
Q3 2022 1.16K +361 +44.9% Sep 30, 2022
Q2 2022 969 +158 +19.4% Jun 30, 2022
Q1 2022 818 -78.2 -8.72% Mar 31, 2022
Q4 2021 798 -200 -20.1% Dec 31, 2021
Q3 2021 804 -289 -26.4% Sep 30, 2021
Q2 2021 812 -505 -38.4% Jun 30, 2021
Q1 2021 896 -619 -40.8% Mar 31, 2021
Q4 2020 998 -644 -39.2% Dec 31, 2020
Q3 2020 1.09K -1.03K -48.4% Sep 30, 2020
Q2 2020 1.32K Jun 30, 2020
Q1 2020 1.52K Mar 31, 2020
Q4 2019 1.64K Dec 31, 2019
Q3 2019 2.12K Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.